Modification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer

Overview of attention for article published in Journal of Hematology & Oncology, September 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

twitter: 25 X users
patent: 2 patents

facebook: 1 Facebook page
reddit: 1 Redditor

Citations

dimensions_citation: 51 Dimensions

Readers on

mendeley: 31 Mendeley

Summary X Patents Facebook Reddit Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

USE OF A KRAS G12C INHIBITOR IN TREATING CANCERS

Application WO-2022150628-A1

World Intellectual Property Organisation (WIPO)

METHODS OF TREATING CANCERS HAVING A DEREGULATED NRF2/KEAP1 PATHWAY

Application WO-2018145090-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.